SLC44A2 (CTL2)

Overview

SLC44A2 (also known as CTL2, Choline Transporter-Like Protein 2) encodes a member of the Solute Carrier Family 44. SLC44A2 is a membrane transporter that was initially identified as a choline transporter, though its exact physiological substrate and function remain an area of active investigation. The protein is expressed in various tissues including the brain, blood cells, and epithelial tissues. SLC44A2 belongs to the SLC44 family, which includes five members (SLC44A1-5) that share structural features but may have distinct functions. Unlike classical neurotransmitter transporters, SLC44A2 appears to function as a housekeeper transporter involved in maintaining cellular choline homeostasis, which is essential for phosphatidylcholine biosynthesis, acetylcholine synthesis, and membrane integrity. Recent studies have implicated SLC44A2 in platelet function, hearing loss, and potentially in neurodegenerative diseases. This page covers SLC44A2’s molecular function, disease associations, expression patterns, and therapeutic implications. ^{1The SLC44 family: a group of orphan transporters2016 · Pflugers Archiv · PMID 26821115Open reference2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}

Molecular Structure and Mechanism

Protein Domain Architecture

SLC44A2 contains structural features characteristic of the SLC44 family:^{8Membrane transporter biology in disease2020 · Journal of Biological Chemistry · PMID 32284344Open reference}

1. N-terminal Extracellular Domain: The N-terminus contains a large extracellular loop with potential N-glycosylation sites. This domain may be involved in substrate recognition and protein-protein interactions.

2. Transmembrane Domains: SLC44A2 is predicted to contain 10-12 transmembrane helices, a characteristic of the major facilitator superfamily. These helices form the translocation pathway for substrate transport.

3. Intracellular Loops: The intracellular loops connecting transmembrane domains contain regulatory motifs including potential phosphorylation sites.

4. C-terminal Cytoplasmic Domain: The C-terminus extends into the cytoplasm and may contain regulatory sequences.

Transport Mechanism

SLC44A2 is thought to operate as a secondary transporter:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}0

1. Substrate Binding: The transporter binds choline (or other potential substrates) from the extracellular space.

2. Conformational Change: Substrate binding triggers a conformational change that translocates the substrate across the membrane.

3. Release: The substrate is released into the cytoplasm.

4. Reset: The transporter returns to its original conformation for another cycle.

The transport may be coupled to the electrochemical gradient (either Na+ or H+ gradient) though the exact coupling mechanism remains to be fully characterized.

Gene Function

Choline Transport

SLC44A2 participates in choline homeostasis:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}1^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}2

• Choline Uptake: SLC44A2 mediates cellular uptake of choline, an essential nutrient.

• Phosphatidylcholine Synthesis: Choline is the precursor for phosphatidylcholine biosynthesis, the most abundant phospholipid in mammalian membranes.

• Acetylcholine Synthesis: Choline is the precursor for acetylcholine, a key neurotransmitter.

• Membrane Maintenance: Choline is required for maintaining membrane integrity and lipid homeostasis.

Lipid Metabolism

SLC44A2 is linked to lipid metabolism:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}3^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}4

• Phosphatidylcholine Biosynthesis: Choline transport supports the CDP-choline pathway for phosphatidylcholine synthesis.

• Membrane Biogenesis: Proper phosphatidylcholine levels are essential for membrane synthesis, particularly in neurons with high membrane turnover.

• Lipid Signaling: Choline-derived lipids serve as signaling molecules.

Cellular Functions

SLC44A2 supports various cellular processes:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}5

• Neuronal Function: Choline transport supports acetylcholine synthesis and synaptic function.

• Cell Proliferation: Adequate choline is required for membrane biosynthesis during cell division.

• Cell Survival: Choline deficiency can lead to apoptosis.

Disease Associations

Alzheimer’s Disease

Choline transport is relevant to Alzheimer’s disease:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}6^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}7

• Choline Deficiency: AD brains show altered choline metabolism, and reduced choline transport may contribute to this deficit.

• Acetylcholine Loss: AD is associated with cholinergic decline; SLC44A2 may contribute to acetylcholine synthesis capacity.

• Membrane Integrity: Phosphatidylcholine loss is observed in AD; reduced choline transport may contribute.

• Therapeutic Implications: Choline supplementation has been explored as a therapeutic approach; understanding SLC44A2 function may improve targeting.

Parkinson’s Disease

Choline dysregulation has been implicated in PD:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}8

• Dopaminergic Neurons: Choline metabolism may be altered in dopaminergic neurons.

• Membrane Homeostasis: Proper membrane function is critical for neuronal survival.

• Signal Transduction: Choline-derived signaling molecules may be relevant to PD pathogenesis.

Platelet Disorders

SLC44A2 is highly expressed in blood cells:^{2SLC44A2 and platelet activation2019 · Journal of Thrombosis and Haemostasis · PMID 30706915Open reference}9^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}0

• Platelet Activation: SLC44A2 variants have been associated with platelet reactivity.

• Thrombosis Risk: Altered SLC44A2 function may influence thrombosis risk.

• Blood Cell Development: SLC44A2 may function in blood cell development.

Cancer

SLC44A2 expression is altered in some cancers:^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}1

• Tumor Metabolism: Cancer cells often show altered choline metabolism.

• Expression Changes: SLC44A2 expression is modified in various cancer types.

• Therapeutic Target: SLC44A2 may represent a metabolic vulnerability in cancer.

Expression Profile

SLC44A2 shows broad but specific expression:^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}2

Tissue Distribution

• Blood Cells: High expression in platelets and leukocytes.

• Brain: Moderate expression in various brain regions.

• Liver: Expression in hepatocytes.

• Lung: Expression in lung tissue.

• Kidney: Expression in renal tissues.

Cellular Expression

• Neuronal Expression: SLC44A2 is expressed in neurons throughout the brain.

• Glial Expression: Astrocytes and other glial cells express SLC44A2.

• Epithelial Cells: Various epithelial tissues express the transporter.

• Blood Cells: Particularly high expression in megakaryocytes and platelets.

Protein Interactions

SLC44A2 participates in protein interactions:^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}3

Transport Complex

• Homomers: SLC44A2 may form homomeric transporters.

• Heteromers: Potential interaction with other SLC44 family members.

Regulatory Proteins

• Kinases: SLC44A2 may be regulated by protein kinases.

• Scaffold Proteins: Interaction with scaffold proteins may target SLC44A2 to specific membrane domains.

Metabolic Enzymes

• Choline Kinases: Downstream enzymes in choline metabolism.

• Acetylcholine Synthesis: Enzymes for acetylcholine production.

Common Variants and Risk Alleles

Variant	Type	Association	Effect	Ref
rs2288903	Missense (P377L)	Platelet reactivity	Altered transport	3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference4
rs4889953	Intronic	AD risk (suggestive)	Altered expression	-
rs10770113	3’UTR	Cancer risk (suggestive)	Altered mRNA stability	-

Therapeutic Implications

Neurodegenerative Disease

SLC44A2 modulation may have therapeutic potential:^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}5^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}6

• Choline Supplementation: Enhancing choline transport may support neuronal function.

• Agonists: Developing SLC44A2-selective agonists to enhance choline uptake.

• Targeted Delivery: Using SLC44A2 for targeted drug delivery.

Cardiovascular Disease

SLC44A2 is relevant to platelet function:^{3Choline transporters in neuronal function2020 · Neurochemistry International · PMID 31706022Open reference}7

• Antithrombotic Targeting: SLC44A2 inhibitors may reduce platelet activation.

• Bleeding Disorders: Understanding SLC44A2 function may help treat bleeding disorders.

Cancer Therapy

Metabolic targeting may benefit cancer treatment:

• Metabolic Vulnerability: Targeting choline metabolism in cancer cells.

• Combination Therapy: Combining choline transporter targeting with standard therapies.

Animal Models

Mouse Models

• Knockout Studies: Slc44a2 knockout mice show viability and some phenotype.

• Transgenic Models: Overexpression to study disease mechanisms.

In Vitro Models

• Cell Lines: Various cell lines expressing SLC44A2 for study.

• Primary Cells: Neurons, platelets, and other primary cells.

See Also

• SLC44 Family — Overview of SLC44 transporters

• Choline Metabolism — Choline biochemical pathways

• Alzheimer’s Disease — AD overview

• Parkinson’s Disease — PD overview

External Links

• NCBI Gene: SLC44A2

• GeneCards: SLC44A2

• UniProt: Q8WWI5

• Ensembl: ENSG00000137767

• OMIM: 609027